Figure 4From: Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasisBevacizumab treatment did not affect SKOV3 cell viability. Bevacizumab treatment (0, 1, 10, 100 and 1000 μg/ml) does not affect SKOV3 cell viability in 3D culture. There were no statistically significant difference (P > 0.05).Back to article page